Market Access South Korea: Emerging global leader in life sciences South Korea has designated life sciences and biotechnology as priority areas for growth and leadership.
Market Access China’s 4+7 drug procurement policy and its impact on the ph... It is estimated that China has around 10,000 pharmaceutical companies varying in size, strategy, and technology.
News Project seeks to shape digital health reimbursement in APAC APACMed and Eversana join forces to draw up coverage frameworks applicable to APAC countries.
Oncology Country focus: China & APAC’s growing medical needs bring op... Dr Jay Mei from Antengene tells us how the Asia Pacific region is opening up to innovative pharma companies, and gives tips for companies navigating this enormous market.
R&D Modelling biologics: Challenges and opportunities, with Dr D... From AAPS 2025, an interview with Dr Dhaval Shah, professor of pharmaceutical sciences at the University of Buffalo and former Pfizer researcher.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.